Chapter 042

Clinical Rationale for and Significance of Prescription Writing

Vahn A. Lewis

GENERAL REFERENCES

  1. Acetominophen prescription combination drug products with more than 325 mg: FDA statement- recommendation to discontinue prescribing and dispensing. Available at: http://ww.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm381650.htm.
  2. Briggs GG, Freeman RK, Yaffe SJ: Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, ed 9, Baltimore, 2011, Williams & Wilkins.
  3. Electronic orange book: approved drug products with therapeutic equivalence evaluations. Available at: http://www.fda.gov/cder/ob. Accessed September 2014.
  4. Food and Drug Administration Modernization Act of 1997. Available at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFood DrugandCosmeticActFDCAct/.
  5. Talley CR: Counseling patients about drug use, Am J Hosp Pharm 48:1196, 1991. PUBMED Abstract
  6. U.S. Department of Health and Human Services: Health information privacy. Available at: http://www.hhs.gov/ocr/privacy/index.html. Accessed September 2015.
  7. U.S. Food and Drug Administration: An introduction to improved FDA prescription drug labeling. Available at: http://www.fda.gov/Training/ ForHealthProfessionals/ucm090590.htm. Accessed September 2015.
  8. U.S. Food and Drug Administration: Buying prescription medicine online: a consumer safety guide. Available at: http://www.fda.gov/Drugs/ ResourcesForYou/ucm080588.htm. Accessed September 2015.
  9. U.S. Food and Drug Administration: CDER drug and biologic approval reports. Available at: http://www.fda.gov/Drugs/Development ApprovalProcess/HowDrugsareDevelopedandApproved/Drugand BiologicApprovalReports/default.htm. Accessed September 2015.
  10. U.S. Food and Drug Administration: Dietary Supplement Health and Education Act of 1994. Available at: https://ods.od.nih.gov/About/DSHEA_ Wording.aspx. Accessed September 2015.